Ramatroban
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
3-((3R)-3-{[(4-fluorophenyl)sulfonyl]amino}-1,2,3,4-tetrahydro-9H-carbazol-9-yl)propanoic acid
|
|
| Clinical data | |
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| CAS Number | 116649-85-5 |
| ATC code | none |
| PubChem | CID: 123879 |
| IUPHAR/BPS | 1910 |
| ChemSpider | 110413 |
| UNII | P1ALI72U6C  |
| ChEMBL | CHEMBL361812 |
| Chemical data | |
| Formula | C21H21FN2O4S |
| Molecular mass | 416.46 g/mol |
|
|
|
|
Ramatroban (INN) is a thromboxane receptor antagonist.[1]
It is also a DP2 receptor antagonist.[2]
It is indicated for the treatment of coronary artery disease.[3] It has also been used for the treatment of asthma.[4]
It was developed by the German pharmaceutical company Bayer AG and is co-marketed in Japan by Bayer and Nippon Shinyaku Co. Ltd. under the tradename Baynas.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." />External links
- (Japanese) Baynas
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |
- Pages with reference errors
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Articles with Japanese-language external links
- Antiplatelet drugs
- Respiratory system drug stubs
- Blood and blood forming organ drug stubs
